Low-dose immunoglobulin G is not associated with mortality in patients with sepsis and septic shock.

Yusuke IizukaMasamitsu SanuiYusuke SasabuchiAlan Kawarai LeforMineji HayakawaShinjiro SaitoShigehiko UchinoKazuma YamakawaDaisuke KudoKohei TakimotoToshihiko MayumiTakeo AzuhataFumihito ItoShodai YoshihiroKatsura HayakawaTsuyoshi NakashimaTakayuki OguraEiichiro NodaYoshihiko NakamuraRyosuke SekineYoshiaki YoshikawaMotohiro SekinoKeiko UenoYuko OkudaMasayuki WatanabeAkihito TampoNobuyuki SaitoYuya KitaiHiroki TakahashiIwao KobayashiYutaka KondoWataru MatsunagaSho NachiToru MiikeHiroshi TakahashiShuhei TakaujiKensuke UmakoshiTakafumi TodakaHiroshi KodairaKohkichi AndohTakehiko KasaiYoshiaki IwashitaHideaki AraiMasato MurataMasahiro YamaneKazuhiro ShigaNaoto Hori

Published in: Critical care (London, England) (2017)

University Hospital Medical Information Network Individual Clinical Trials Registry, UMIN-CTR000012543 . Registered on 10 December 2013.

Keyphrases

septic shock
low dose
clinical trial
cardiovascular events
high dose
healthcare
health information
risk factors
phase ii
open label
intensive care unit
phase iii
network analysis